Market Overview:
The global immunohematology market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of blood-related diseases, rising demand for blood transfusions, and technological advancements in immunohematology analyzers and systems. However, the high cost of immunohematology equipment may restrain the growth of this market during the forecast period. The global immunohematology market is segmented on the basis of type, application, and region. On the basis of type, it is divided into immunohematology analyzers and systems and immunohematology reagents.
Product Definition:
Immunohematology is the study of blood transfusion and blood disorders. It is important because it ensures that safe blood transfusions occur, and that people with blood disorders receive appropriate treatment.
Immunohematology Analyzers and Systems:
An immunohematology analyzers and systems is a tool that helps in analyzing the blood for various infectious diseases, autoimmune disorders, and other medical conditions. The global Immunohematology market size was valued at USD 2.5 billion in 2015 and is expected to grow at a CAGR of XX% during the forecast period.
Immunohematology Reagent:
An immunohematology reagent is a preparation used for the detection of blood in urine and vice versa. Immunohematology tests are performed to detect diseases related to blood clotting, such as hemophilia. These tests involve the use of specific reagents that help identify different components present in the blood sample.
Global Immunohematology Reagent.
Application Insights:
Based on application, the global immunohematology market is segmented into blood-related diseases, HIV, hepatitis and other infections. The blood-related diseases segment dominated the overall market in terms of revenue share in 2017. This can be attributed to a large number of immunohematology tests that are performed for various conditions related to the immune system such as allergy & intolerances, anemia & hemoglobin disorders and autoimmune disease.
The HIV infection testing segment is expected to witness lucrative growth during the forecast period owing to increasing prevalence of HIV worldwide coupled with a rise in demand for rapid diagnostic solutions. According to UNAIDS Report 2016: Country Profile Series (CPS), there were 37 million people living with AIDS across Sub-Saharan Africa; 9 million more than five years ago.
Regional Analysis:
North America dominated the global immunohematology market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies, and favorable reimbursement policies pertaining to blood-related disorders. The U.S., which is at the forefront of this region, has one of the highest per capita income levels resulting in better access to healthcare facilities and improved diagnosis & treatment rates for various blood-related disorders such as leukemia & lymphoma, multiple sclerosis (MS), sickle cell disease (SCD), etc. Moreover, a well-developed healthcare infrastructure with an established research framework for immunohematology studies also contributes toward regional growth prospects.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure due to increasing government spending on health care; rising awareness regarding HIV/AIDS related diseases; increase in disposable income leading toward increased demand for technologically advanced products; etc.).
Growth Factors:
- Increasing incidence of blood disorders and cancer
- Growing demand for safe and effective blood transfusion therapies
- Rising awareness about immunohematology testing procedures
- Technological advancements in immunohematology diagnostics instruments
- Proliferation of private diagnostic laboratories
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunohematology Market Research Report
By Type
Immunohematology Analyzers and Systems, Immunohematology Reagent
By Application
Blood-Related Diseases, HIV, Hepatitis
By Companies
Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostic, BD, Beckman Coulter, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, MTC INVITRO, Seqirus, Tulip Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Immunohematology Market Report Segments:
The global Immunohematology market is segmented on the basis of:
Types
Immunohematology Analyzers and Systems, Immunohematology Reagent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood-Related Diseases, HIV, Hepatitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- Grifols
- Immucor
- Ortho Clinical Diagnostic
- BD
- Beckman Coulter
- DIAGAST
- Hemo bioscience
- Institut de Biotechnologies Jacques Boy
- MTC INVITRO
- Seqirus
- Tulip Group
Highlights of The Immunohematology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunohematology Analyzers and Systems
- Immunohematology Reagent
- By Application:
- Blood-Related Diseases
- HIV
- Hepatitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunohematology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunohematology is the study of blood and blood-forming organs in relation to diseases. It includes the identification and characterization of antigens, antibodies, and other immune system proteins in blood samples from patients with disease. Immunohematology can also help identify potential targets for new therapies or vaccines against diseases.
Some of the major players in the immunohematology market are Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostic, BD, Beckman Coulter, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, MTC INVITRO, Seqirus, Tulip Group.
The immunohematology market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunohematology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunohematology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunohematology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunohematology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunohematology Market Size & Forecast, 2018-2028
4.5.1 Immunohematology Market Size and Y-o-Y Growth
4.5.2 Immunohematology Market Absolute $ Opportunity
Chapter 5 Global Immunohematology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunohematology Market Size Forecast by Type
5.2.1 Immunohematology Analyzers and Systems
5.2.2 Immunohematology Reagent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunohematology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunohematology Market Size Forecast by Applications
6.2.1 Blood-Related Diseases
6.2.2 HIV
6.2.3 Hepatitis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunohematology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunohematology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunohematology Analysis and Forecast
9.1 Introduction
9.2 North America Immunohematology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunohematology Market Size Forecast by Type
9.6.1 Immunohematology Analyzers and Systems
9.6.2 Immunohematology Reagent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunohematology Market Size Forecast by Applications
9.10.1 Blood-Related Diseases
9.10.2 HIV
9.10.3 Hepatitis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunohematology Analysis and Forecast
10.1 Introduction
10.2 Europe Immunohematology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunohematology Market Size Forecast by Type
10.6.1 Immunohematology Analyzers and Systems
10.6.2 Immunohematology Reagent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunohematology Market Size Forecast by Applications
10.10.1 Blood-Related Diseases
10.10.2 HIV
10.10.3 Hepatitis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunohematology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunohematology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunohematology Market Size Forecast by Type
11.6.1 Immunohematology Analyzers and Systems
11.6.2 Immunohematology Reagent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunohematology Market Size Forecast by Applications
11.10.1 Blood-Related Diseases
11.10.2 HIV
11.10.3 Hepatitis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunohematology Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunohematology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunohematology Market Size Forecast by Type
12.6.1 Immunohematology Analyzers and Systems
12.6.2 Immunohematology Reagent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunohematology Market Size Forecast by Applications
12.10.1 Blood-Related Diseases
12.10.2 HIV
12.10.3 Hepatitis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunohematology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Type
13.6.1 Immunohematology Analyzers and Systems
13.6.2 Immunohematology Reagent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Applications
13.10.1 Blood-Related Diseases
13.10.2 HIV
13.10.3 Hepatitis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunohematology Market: Competitive Dashboard
14.2 Global Immunohematology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 Grifols
14.3.3 Immucor
14.3.4 Ortho Clinical Diagnostic
14.3.5 BD
14.3.6 Beckman Coulter
14.3.7 DIAGAST
14.3.8 Hemo bioscience
14.3.9 Institut de Biotechnologies Jacques Boy
14.3.10 MTC INVITRO
14.3.11 Seqirus
14.3.12 Tulip Group
